Spearhead Capital Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-25,718	Closed	-$410K	–	202
2021 Q4	$410K	Buy	25,718 +298	+1%	+$4.75K	0.05%	116
2021 Q3	$408K	Sell	25,420 -188	-0.7%	-$3.02K	0.05%	123
2021 Q2	$354K	Buy	25,608 +4,179	+20%	+$57.8K	0.05%	162
2021 Q1	$313K	Buy	+21,429	New	+$313K	0.05%	159